220 related articles for article (PubMed ID: 22766303)
1. KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells.
Sellak H; Wu S; Lincoln TM
Biochim Biophys Acta; 2012 Oct; 1823(10):1666-75. PubMed ID: 22766303
[TBL] [Abstract][Full Text] [Related]
2. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
4. Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.
Narasipura SD; Henderson LJ; Fu SW; Chen L; Kashanchi F; Al-Harthi L
J Virol; 2012 Feb; 86(4):1911-21. PubMed ID: 22156527
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
Huang BL; Brugger SM; Lyons KM
J Biol Chem; 2010 Sep; 285(36):27702-12. PubMed ID: 20571031
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.
Sengupta PK; Bouchie MP; Kukuruzinska MA
J Biol Chem; 2010 Oct; 285(41):31164-73. PubMed ID: 20693288
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.
Guo L; He P; No YR; Yun CC
Cell Signal; 2015 May; 27(5):961-8. PubMed ID: 25683913
[TBL] [Abstract][Full Text] [Related]
8. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.
Ungerbäck J; Elander N; Grünberg J; Sigvardsson M; Söderkvist P
PLoS One; 2011 Mar; 6(3):e17957. PubMed ID: 21437251
[TBL] [Abstract][Full Text] [Related]
9. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
10. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin.
Evans PM; Chen X; Zhang W; Liu C
Mol Cell Biol; 2010 Jan; 30(2):372-81. PubMed ID: 19901072
[TBL] [Abstract][Full Text] [Related]
11. High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression.
Zhang J; Huang K; Shi Z; Zou J; Wang Y; Jia Z; Zhang A; Han L; Yue X; Liu N; Jiang T; You Y; Pu P; Kang C
Neuro Oncol; 2011 Jun; 13(6):600-9. PubMed ID: 21636708
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel fluorescence polarization-based assay for studying the β-catenin/Tcf4 interaction.
Tian W; Xu Y; Han X; Duggineni S; Han X; Huang Z; An J
J Biomol Screen; 2012 Apr; 17(4):530-4. PubMed ID: 22127421
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
Parr C; Mirzaei N; Christian M; Sastre M
FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
[TBL] [Abstract][Full Text] [Related]
15. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
[TBL] [Abstract][Full Text] [Related]
16. Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.
Wu J; Richards MH; Huang J; Al-Harthi L; Xu X; Lin R; Xie F; Gibson AW; Edberg JC; Kimberly RP
PLoS One; 2011; 6(10):e26143. PubMed ID: 22022540
[TBL] [Abstract][Full Text] [Related]
17. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
[TBL] [Abstract][Full Text] [Related]
18. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
20. SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer.
Ramakrishnan AB; Burby PE; Adiga K; Cadigan KM
J Biol Chem; 2023 Jan; 299(1):102735. PubMed ID: 36423688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
